We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+18.84%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.76B
AUM Growth
+$318M
Cap. Flow
+$3.28M
Cap. Flow %
0.12%
Top 10 Hldgs %
33.65%
Holding
126
New
10
Increased
35
Reduced
63
Closed
14

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$24.5M
2
NFLX icon
Netflix
NFLX
+$23.9M
3
DGX icon
Quest Diagnostics
DGX
+$23.6M
4
QXO
QXO Inc
QXO
+$20.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$19.5M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.7M
2
MRVL icon
Marvell Technology
MRVL
+$15.5M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
TTD icon
Trade Desk
TTD
+$14M
5
HWM icon
Howmet Aerospace
HWM
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 29.99%
2 Financials 14.25%
3 Communication Services 11.45%
4 Industrials 9.49%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
51
American Express
AXP
$230B
$22.6M 0.82%
70,857
-32,340
-31% -$9.1M
TRGP icon
52
Targa Resources
TRGP
$55.1B
$22.4M 0.81%
128,487
+2,759
+2% +$463K
KO icon
53
Coca-Cola
KO
$375B
$22.2M 0.8%
313,564
-938
-0.3% -$66.8K
CSCO icon
54
Cisco
CSCO
$479B
$22M 0.8%
317,408
+174,730
+122% +$10.7M
KD icon
55
Kyndryl
KD
$3.05B
$21.7M 0.79%
517,259
+289,724
+127% +$10.5M
CL icon
56
Colgate-Palmolive
CL
$74.4B
$21.6M 0.78%
238,048
-10,079
-4% -$920K
COST icon
57
Costco
COST
$420B
$21.6M 0.78%
21,829
-1,523
-7% -$1.51M
NBIX icon
58
Neurocrine Biosciences
NBIX
$16.6B
$21.4M 0.77%
+170,370
New +$19.5M
ACGL icon
59
Arch Capital
ACGL
$33.6B
$21.3M 0.77%
234,330
-8,216
-3% -$758K
CORT icon
60
Corcept Therapeutics
CORT
$12B
$21.1M 0.76%
287,254
-79,365
-22% -$5.75M
PG icon
61
Procter & Gamble
PG
$339B
$20.5M 0.74%
128,724
+306
+0.2% +$49.9K
HD icon
62
Home Depot
HD
$355B
$19.8M 0.72%
53,947
+283
+0.5% +$102K
POST icon
63
Post Holdings
POST
$3.57B
$19.6M 0.71%
179,548
-30,080
-14% -$3.37M
TKO icon
64
TKO Group
TKO
$13.6B
$19.2M 0.7%
105,567
+63,312
+150% +$10.2M
APH icon
65
Amphenol
APH
$209B
$19.2M 0.69%
+194,426
New +$15.9M
SN icon
66
SharkNinja
SN
$26.1B
$19.1M 0.69%
192,704
+29,396
+18% +$2.54M
VOO icon
67
Vanguard S&P 500 ETF
VOO
$1.01T
$19M 0.69%
33,455
+250
+0.8% +$131K
VICI icon
68
VICI Properties
VICI
$29.4B
$18.9M 0.68%
579,937
-16,234
-3% -$517K
BRBR icon
69
BellRing Brands
BRBR
$1.34B
$18.7M 0.68%
323,342
-20,299
-6% -$1.35M
TGTX icon
70
TG Therapeutics
TGTX
$7.62B
$18.6M 0.67%
518,015
+15,365
+3% +$572K
LDOS icon
71
Leidos
LDOS
$17.3B
$18.2M 0.66%
115,626
-28,623
-20% -$4.23M
AEE icon
72
Ameren
AEE
$30.1B
$18M 0.65%
187,838
+666
+0.4% +$64.7K
NUE icon
73
Nucor
NUE
$62.1B
$17.4M 0.63%
134,194
+2,580
+2% +$301K
TECK icon
74
Teck Resources
TECK
$32.6B
$17M 0.61%
420,485
-334
-0.1% -$12.1K
TEAM icon
75
Atlassian
TEAM
$37.8B
$15.8M 0.57%
77,741
+26,129
+51% +$5.44M
1 2
3
4 5

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return

Braun Stacey Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Braun Stacey Associates held 126 positions worth $2.76B, up 13% from $2.45B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q2 2025 filing shows 10 new, 35 increased, 63 reduced and 14 closed positions. Its largest new stake was CME Group: 89,918 shares worth $24.8M. The largest sale was Vertex Pharmaceuticals, an estimated $21.7M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q2 2025 buy was CME Group: 89,918 shares worth $24.8M.
  • Braun Stacey Associates added most to Celsius Holdings in Q2 2025, an estimated $13.6M increase.
  • Braun Stacey Associates's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $14.4M.
  • Braun Stacey Associates fully exited Vertex Pharmaceuticals in Q2 2025, selling an estimated $21.7M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.76B portfolio in Q2 2025.
  • Braun Stacey Associates opened 10 new positions and closed 14 in Q2 2025.
  • Braun Stacey Associates's portfolio value rose 13% quarter-over-quarter to $2.76B.

Based on Braun Stacey Associates's 13F filing for Q2 2025, filed 12 Aug 2025.